Toward future therapies in progressive supranuclear palsy

Authors

  • David J. Burn MD, FRCP,

    Corresponding author
    1. Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
    • Regional Neurosciences Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, United Kingdom
    Search for more papers by this author
  • Naomi M. Warren MRCP

    1. Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
    Search for more papers by this author

Abstract

There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review progress to date in this area and briefly consider future potential therapeutic strategies. © 2005 Movement Disorder Society

Ancillary